Adaptive neoadjuvant chemotherapy guided by (18)F-FDG-PET in resectable non-small-cell lung cancers: the NEOSCAN trial

INTRODUCTION: Although perioperative chemotherapy improves survival in patients with resectable lung cancers, systemic recurrence remains common. Neoadjuvant chemotherapy permits response assessment and opportunity to switch treatment regimens. Response measured by fluorodeoxyglucose PET correlates...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thorac Oncol
Main Authors: Chaft, Jamie E., Dunphy, Mark, Naidoo, Jarushka, Travis, William D., Hellmann, Matthew, Woo, Kaitlin, Downey, Robert, Rusch, Valerie, Ginsberg, Michelle S., Azzoli, Christopher G., Kris, Mark G.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808609/
https://ncbi.nlm.nih.gov/pubmed/26724474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2015.12.104
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki